Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05091320Phase 3Unknown
Phase 3, randomised, open-label trial in ischemic stroke (2 arms), sponsored by Assiut University. Primary endpoint: Clinical neurological outcome at 3 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05091320.